Startups
TFC Therapeutics
Develops biologic medicines targeting tumor-macrophage hybrid cells implicated in cancer metastasis, treatment resistance and recurrence. Its discovery platform builds on licensed Columbia University research to investigate new ways of eliminating these cancer-associated cells.
Team
Jennifer PowerChief Executive Officer |
 Steven GillisBoard Chairman (reported August 2023) |